Stryker Corp (SYK)

337.43
+0.40 (0.12%)
NYSE· Last Trade: Aug 7th, 12:17 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close337.03
Open340.45
Bid332.00
Ask345.66
Day's Range334.24 - 343.87
52 Week Range281.00 - 396.86
Volume1,803,311
Market Cap127.24B
PE Ratio (TTM)44.34
EPS (TTM)7.6
Dividend & Yield3.520 (1.04%)
1 Month Average Volume2,479,608

Chart

About Stryker Corp (SYK)

Stryker Corporation is a leading medical technology company that specializes in designing, manufacturing, and marketing innovative products and services for healthcare professionals and patients. The company offers a diverse range of medical devices, including surgical equipment, orthopedic implants, neurotechnology, and surgery assistance products. Stryker focuses on advancing healthcare through cutting-edge technology and solutions that enhance patient care, improve surgical outcomes, and streamline hospital operations. With a commitment to innovation and quality, Stryker plays a pivotal role in the medical industry, helping healthcare providers deliver effective treatment and improve the quality of life for patients around the world. Read More

News & Press Releases

The 5 Most Interesting Analyst Questions From Stryker’s Q2 Earnings Call
Stryker’s second quarter results met Wall Street’s revenue expectations, yet the market responded negatively, reflecting investor concerns about the company’...
Via StockStory · August 6, 2026
Stryker declares an $0.88 per share quarterly dividend
Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter. 
By Stryker Corporation · Via GlobeNewswire · August 5, 2026
Stryker (SYK) Q2 2026 Earnings Call Transcriptfool.com
CEO Lobo discusses 9% organic sales growth and margin expansion amid cybersecurity recovery.
Via The Motley Fool · August 3, 2026
Stryker (NYSE:SYK): A Dividend Quality Play Built on Sustainabilitychartmill.com
Via Chartmill · August 3, 2026
Stryker (NYSE:SYK) Slips After Q2 Revenue Miss Overshadows Earnings Beatchartmill.com
Via Chartmill · July 30, 2026
Stryker Corp (NYSE:SYK): A High-Grade Dividend Stock for Sustainable Incomechartmill.com
Via Chartmill · July 6, 2026
Stryker Q2 Earnings Call Highlightsmarketbeat.com
Stryker (NYSE:SYK) reported 9% organic sales growth in the second quarter of 2026 and adjusted earnings per share growth of 17.9%, as the medical technology company continued recovering from a cybersecurity incident that disrupted operations earlier in the year. Chair and CEO Kevin Lobo said the co
Via MarketBeat · July 31, 2026
Stay informed with the top movers within the S&P500 index on Friday.chartmill.com
Via Chartmill · July 31, 2026
Friday's session: top gainers and losers in the S&P500 indexchartmill.com
Via Chartmill · July 31, 2026
Why Stryker (SYK) Shares Are Plunging Today
What Happened? Shares of medical technology company Stryker (NYSE:SYK) fell 7.3% in the morning session after the company reported second-quarter results tha...
Via StockStory · July 31, 2026
These S&P500 stocks are gapping in today's sessionchartmill.com
Via Chartmill · July 31, 2026
Get insights into the top movers in the S&P500 index of Friday's pre-market session.chartmill.com
Via Chartmill · July 31, 2026
SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion
Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-...
Via StockStory · July 31, 2026
Stryker (SYK) Q2 2026 Earnings Call Transcriptfool.com
CEO Lobo discusses 9% organic sales growth and margin expansion amid cybersecurity recovery.
Via The Motley Fool · July 30, 2026
Stryker (NYSE:SYK) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops
Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-...
Via StockStory · July 30, 2026
Which S&P500 stocks are moving after the closing bell on Thursday?chartmill.com
Via Chartmill · July 30, 2026
Stryker reports second quarter 2026 operating results
Portage, Michigan, July 30, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2026:
By Stryker Corporation · Via GlobeNewswire · July 30, 2026
Stryker (SYK) Q2 Earnings Report Preview: What To Look For
Medical technology company Stryker (NYSE:SYK) will be reporting earnings this Thursday afternoon. Here’s what investors should know. Stryker missed analysts’...
Via StockStory · July 28, 2026
These S&P500 stocks are gapping in today's sessionchartmill.com
Via Chartmill · July 28, 2026
Here’s How Much You Would Have Made Owning Stryker Stock In The Last 20 Yearsbenzinga.com
Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.04% on an annualized basis producing an average annual return of 10.3%. Currently, Stryker has a market capitalization of $122.02 billion.
Via Benzinga · July 20, 2026
These S&P500 stocks are gapping in today's sessionchartmill.com
Via Chartmill · July 17, 2026
Discover which S&P500 stocks are making waves on Tuesday.chartmill.com
Via Chartmill · July 14, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · July 14, 2026
What's going on in today's session: S&P500 gap up and gap down stockschartmill.com
Via Chartmill · July 14, 2026
1 Cash-Producing Stock Worth Your Attention and 2 Facing Challenges
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via StockStory · July 2, 2026